Index Investing News
Friday, March 20, 2026
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

India defends cough syrups linked to Gambia child deaths

by Index Investing News
December 16, 2022
in World
Reading Time: 3 mins read
A A
2
Home World
Share on FacebookShare on Twitter


The WHO had advised regulators to stop the sale of the four Indian-made cough syrups

India has said that four cough syrups linked to child deaths in the Gambia were found to be complying with safety specifications when tested at home.

The WHO had said in October that the four syrups – made by India’s Maiden Pharmaceuticals – may be linked to the deaths of at least 66 children.

But India’s drug regulator said in a letter that the WHO has not provided any evidence yet.

India is a major supplier of generic drugs to Africa.

The letter, dated 13 December, was written by Dr VG Somani, India’s drugs controller general, and addressed to Rogerio Gaspar, director of regulation and prequalification at the WHO.

India had said in October that it was investigating the cough syrups after the WHO issued an alert.

The WHO said it had tested samples of the syrups – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – and found that they contained “unacceptable amounts of diethylene glycol and ethylene glycol as contaminants”.

Diethylene glycol and ethylene glycol are toxic to humans and could be fatal if consumed.

But in his letter, Dr Somani said that the samples it tested at a government laboratory “were found not to have been contaminated” with the compounds. The junior minister for chemicals and fertilisers, Bhagwanth Khuba, also told Parliament this week that the cough syrup samples “were declared to be of standard quality” by a government analyst at the Regional Drug Testing Laboratory in Chandigarh.

The test results are being further examined by a panel of Indian experts.

Dr Somani added that the panel had also requested “specific information” from the WHO on “further details essential to establish the causality” but had not received this yet. The letter did not specify what information the committee had asked for.

When contacted, Dr Somani’s office asked the BBC to get in touch with India’s health ministry. The BBC has emailed the ministry and the WHO for comment.

A senior adviser to India’s information and broadcasting ministry told the BBC that the WHO had been “presumptuous” in blaming the cough syrups for the deaths of the children.

“Subsequent inspections, tests and studies by Government of India’s notified bodies and technical team have shown that WHO’s presumptuous statement was untrue and incorrect,” said Kanchan Gupta, adding that the WHO had “[jumped] the gun without valid scientific reasons”.

The WHO’s intervention came after medical authorities in The Gambia detected an increase in cases of acute kidney injury among children under the age of five in late July. The government later said around 69 children had died from these injuries.

But a representative of The Gambia’s national regulator said in late October that it had not yet confirmed whether the medicines were responsible for the deaths.

“We haven’t concluded yet it is the medicine that caused it. A good number of kids died without taking any medications,” Tijan Fallow said, according to Reuters.

Read more India stories from the BBC:



Source link

Tags: ChildcoughdeathsdefendsGambiaIndiaLinkedsyrups
ShareTweetShareShare
Previous Post

Upcoming Budget to follow spirit of earlier editions: Finance Minister Sitharaman

Next Post

ACN Earnings: Key quarterly highlights from Accenture’s Q1 2023 financial results

Related Posts

Why Hitler still finds admirers in Pakistan

Why Hitler still finds admirers in Pakistan

by Index Investing News
March 16, 2026
0

Admiration for Adolf Hitler should be morally unthinkable anywhere. Yet in parts of Pakistan, his name still surfaces in conversations...

Three Potential Succession Scenarios for Russia’s Modern Tsar – The Cipher Brief

Three Potential Succession Scenarios for Russia’s Modern Tsar – The Cipher Brief

by Index Investing News
March 12, 2026
0

The short answer is that a popular uprising in Russia is still highly unlikely. The FSB and other Russian security...

Lebanon ‘dragged back into turmoil’, UN envoy warns — Global Issues

Lebanon ‘dragged back into turmoil’, UN envoy warns — Global Issues

by Index Investing News
March 8, 2026
0

Just a week ago, Lebanon had been “in relatively good shape”, Jeanine Hennis‑Plasschaert, the UN Special Coordinator for Lebanon, said...

U.S. Navy submarine destroys Iranian warship

U.S. Navy submarine destroys Iranian warship

by Index Investing News
March 4, 2026
0

Key PointsThe United States Navy sank the Iranian frigate IRIS Dana with a submarine-launched torpedo in the Indian Ocean near...

Inside Israel’s ‘normal’: Triumphalism and calm mix after attack on Iran | Israel-Iran conflict News

Inside Israel’s ‘normal’: Triumphalism and calm mix after attack on Iran | Israel-Iran conflict News

by Index Investing News
February 28, 2026
0

Listen to this article | 4 minsinfoCommentators within Israel have described a sense of business as usual in the wake of the...

Next Post
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2023 financial results

ACN Earnings: Key quarterly highlights from Accenture’s Q1 2023 financial results

The big money US military contractors are making in Ukraine’s war, explained by an invitation

The big money US military contractors are making in Ukraine’s war, explained by an invitation

RECOMMENDED

China’s Ambassador Chen ushers in a Year of the Dragon with promises of a ‘shared future’

China’s Ambassador Chen ushers in a Year of the Dragon with promises of a ‘shared future’

January 31, 2024
Harris has what it takes to beat, united America

Harris has what it takes to beat, united America

July 23, 2024
Crypto Bull Run is Coming? Get Prepared for Most Features! En/Id | by Muhamad Yusup / Cupi Crypto | The Capital | Oct, 2024

Crypto Bull Run is Coming? Get Prepared for Most Features! En/Id | by Muhamad Yusup / Cupi Crypto | The Capital | Oct, 2024

October 22, 2024
Luxurious Actual Property Headlines: Third Week in August 2022 – Sotheby´s Worldwide Realty

Luxurious Actual Property Headlines: Third Week in August 2022 – Sotheby´s Worldwide Realty

August 19, 2022
Common property insurance coverage cost up 52% for single-family properties from 2020, says ICE VP Andy Walden

Common property insurance coverage cost up 52% for single-family properties from 2020, says ICE VP Andy Walden

October 13, 2024
3 REITs To Promote Earlier than 2025

3 REITs To Promote Earlier than 2025

December 26, 2024
A Marketplace of Girl Influencers Managed by Moms and Stalked by Men

A Marketplace of Girl Influencers Managed by Moms and Stalked by Men

February 23, 2024
Wealthy Boomers, Broke Millennials, Bold Gen Z Battle for Housing

Wealthy Boomers, Broke Millennials, Bold Gen Z Battle for Housing

October 28, 2024
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In